People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Valtech Cardio: The Israeli start-up named former Boston Scientific executive Bruce H. KenKnight its new president and CEO Feb. 9. KenKnight most recently served as VP-Research and Business Development for Boston Sci's Cardiac Rhythm Management division. Earlier this month, Valtech raised $17.8 million in a Series B financing to aid its development of minimally invasive surgical and transcatheter mitral valve repair and replacement devices
You may also be interested in...
People In Brief
JenaValve, Predictive Biosciences, DexCom among firms with personnel news.
SenoRx names Buhler CEO
Breast cancer device maker appoints John T. Buhler CEO, effective immediately, the firm announces March 16. Buhler, formerly president and chief operating officer, had been acting CEO since former CEO Lloyd H. Malchow went on medical leave in February (1"The Gray Sheet" Feb. 22, 2010). Malchow passed away on March 14
SenoRx names Buhler CEO
Breast cancer device maker appoints John T. Buhler CEO, effective immediately, the firm announces March 16. Buhler, formerly president and chief operating officer, had been acting CEO since former CEO Lloyd H. Malchow went on medical leave in February (1"The Gray Sheet" Feb. 22, 2010). Malchow passed away on March 14